BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9564642)

  • 1. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J; Quigley MM
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
    Steck T; Würfel W; Witteler M; Albert P
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction with gonadotropins in women with polycystic ovary disease.
    Kupferminc MJ; Lessing JB; Peyser MR
    J Reprod Med; 1991 Jan; 36(1):61-4. PubMed ID: 1901089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
    Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A
    Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
    Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
    Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
    Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS; Seibel MM
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 2000; 1996(2):CD000087. PubMed ID: 10796690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease.
    Rossmanith WG; Sterzik K; Wolf AS
    Int J Fertil; 1987; 32(6):460-6. PubMed ID: 2891635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of anovulation in polycystic ovary syndrome with clomiphene citrate in 10-day cycles].
    Porcile A; Venegas E; Gallardo E
    Rev Chil Obstet Ginecol; 1989; 54(2):94-7. PubMed ID: 2490173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.
    Ron-El R; Caspi E; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
    Int J Fertil; 1991; 36(3):157-61. PubMed ID: 1678370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of microsurgical resection of the ovary on fertility in patients with polycystic ovary resistant to clomiphene citrate].
    Devoto L; Sir T; Izquierdo CA; Alba F; Fuentes A
    Rev Chil Obstet Ginecol; 1991; 56(2):94-8. PubMed ID: 1844618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
    Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins.
    Charbonnel B; Krempf M; Blanchard P; Dano F; Delage C
    Fertil Steril; 1987 Jun; 47(6):920-4. PubMed ID: 2954858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovulation induction with a combination of LHRH analogue and hMG pulsatile subcutaneous administration in PCO patients].
    Nakamura Y; Yoshimura Y; Tamaoka Y; Yamada H; Iizuka R; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2157-64. PubMed ID: 3123581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
    Franks S; Sagle M; Mason HD; Kiddy D
    Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].
    Emperaire JC; Ruffié A; Audebert AJ
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):621-6. PubMed ID: 3117873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.